AstraZeneca
AZN
$77.24
Share price
-0.25%
Change (1 day)
3.00%
Change (1 year)
Categories
P/S ratio for AstraZeneca (AZN)
P/S ratio as of May 2024 (TTM): 5.04
According to AstraZeneca's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.04231. At the end of 2023 the company had a P/S ratio of 4.56.
P/S ratio history for AstraZeneca from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.56 | -3.93% |
| 2022 | 4.74 | -2.19% |
| 2021 | 4.85 | -1.45% |
| 2020 | 4.92 | -8.31% |
| 2019 | 5.37 | 25.56% |
| 2018 | 4.27 | 10.21% |
| 2017 | 3.88 | 29.36% |
| 2016 | 3.00 | -14.32% |
| 2015 | 3.50 | 3.59% |
| 2014 | 3.38 | 17.2% |
| 2013 | 2.88 | 37.53% |
| 2012 | 2.10 | 17.67% |
| 2011 | 1.78 | -8.96% |
| 2010 | 1.96 | -5.78% |
| 2009 | 2.08 | 10.47% |
| 2008 | 1.88 | -10.96% |
| 2007 | 2.11 | -31.88% |
| 2006 | 3.10 | -4.92% |
| 2005 | 3.26 | 16.72% |
| 2004 | 2.79 | -35.74% |
| 2003 | 4.35 | 27.15% |
| 2002 | 3.42 | -1.11% |
| 2001 | 3.46 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 4.06 | -19.50% | 🇺🇸 USA |
 Novartis NVS | 4.18 | -17.11% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.75 | -45.36% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.54 | -9.88% | 🇺🇸 USA |
 Eli Lilly LLY | 20.0 | 297.46% | 🇺🇸 USA |
 Sanofi SNY | 2.52 | -49.95% | 🇫🇷 France |
 Biogen BIIB | 3.40 | -32.66% | 🇺🇸 USA |
 Merck MRK | 5.45 | 8.03% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2.01 | -60.22% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.40 | -52.46% | 🇬🇧 UK |